La catena delle opzioni mostra i dati chiave delle opzioni azionarie di MSP Recovery a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per MSP Recovery..

MSP Recovery (NASDAQ:MSPR) Azioni, Catena delle Opzioni

MSP Recovery

MSP Recovery Inc is a healthcare recovery and data analytics company. The business model includes two principal lines of business: Claims Recovery and Chase to Pay Services. It offers an antiquated healthcare reimbursement system with data-driven solutions to secure recoveries against responsible parties. MSP Recovery provides the healthcare industry with comprehensive compliance solutions platform to recover any claims where the law places primary payment responsibility on another payer.

MSP Recovery, Inc. - Class A Common Stock

MSP Recovery Inc

Biomerica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMRA#NASDAQ">BMRA</a>) reported quarterly losses of $(0.06) per share. This is a 45.45 percent increase over losses of $(0.11) per share from the same period last year. The company reported $1.12 million in sales this quarter. This is a 10.03 percent increase over sales of $1.02 million the same period last year.

Earnings

News

BMRA

Biomerica Q3 EPS $(0.06) Up From $(0.11) YoY, Sales $1.12M Up From $1.02M YoY

HOUSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Amplify Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMPY#NYSE">AMPY</a>) ("Amplify" or the "Company") today announced an amendment to the existing terms of its previously disclosed Agreement and Plan of Merger with Juniper Capital's ("Juniper") upstream Rocky Mountain portfolio companies.
The amended agreement will now provide for Juniper to contribute an incremental $10 million of cash to further reduce the net debt of the combined companies. This amendment follows shareholder engagement and reflects Juniper's strong belief in the merits of the combination and focus on a strong pro forma company. As previously announced, at closing Amplify plans to issue Juniper approximately 26.7 million shares of Amplify common stock and assume approximately $133 million in net debt(1).
Such incremental contribution was agreed to in Amendment No. 1 to the Agreement and Plan of Merger, dated April 14, 2025 (the "Amendment"). Amplify intends to file supplemental proxy materials with the Securities and Exchange Commission (the "SEC") in the coming days reflecting the Amendment.
Martyn Willsher, Amplify's President and Chief Executive Officer, said, "These amended terms reflect each party's belief in the long-term value creation of this proposed transaction and our commitment to shareholder engagement. This transaction has been thoroughly considered alongside a wide range of options by our board of directors, and we continue to believe that this combination is the best path for shareholders to realize the value they deserve."
Edward Geiser, Juniper's Managing Partner, added, "In recognition of the recent market volatility, we believe the additional cash investment is justified to bolster the strength and liquidity of the combined company. We continue to believe that the combination of our Rockies assets with Amplify's existing operations offers investors a unique opportunity, which is capable of delivering significant shareholder value and free cash flow in a low or high commodity price environment. This increased capital investment reflects our continued confidence in the long-term value creation of the combined company and the top quality of the Amplify management team."
Updated Hedge Positions
In response to shareholder concerns regarding the recent reduction in oil prices, Amplify is providing updated information regarding the current oil and gas hedge positions at both Amplify and Juniper.
Updated Juniper Audited Reserves
Amplify is also providing updated information regarding the audited reserve value associated with Juniper's assets. Assuming WTI oil prices at $60 per barrel held flat and Henry Hub gas prices at $3.50 per mmbtu held flat, the total proved reserve PV-10(2)&nbsp;value of Juniper's audited reserves is $356 million.

AMPY

Amplify Energy Announces Amendment To Existing Terms Of Merger Agreement With Juniper Capital's Upstream Rocky Mountain Portfolio Companies; Juniper To Contribute Incremental $10M In Cash

Wells Fargo analyst Mohit Bansal downgrades Ironwood Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRWD#NASDAQ">IRWD</a>) from Overweight to Equal-Weight and lowers the price target from $7 to $1.

Downgrades

Price Target

Analyst Ratings

IRWD

Wells Fargo Downgrades Ironwood Pharmaceuticals to Equal-Weight, Lowers Price Target to $1

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 50 points on Tuesday.
Shares of Applied Digital Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>) fell sharply in today's pre-market trading following <a href="https://in.benzinga.com/news/earnings/25/04/44802241/applied-digital-q3-earnings-revenue-misses-estimates-despite-strong-cloud-services-growth-shares-slide">weak quarterly revenue.</a>
Applied Digital reported third-quarter revenue of $52.9 million, missing analyst estimates of $63.42 million, according to Benzinga Pro. The digital infrastructure company reported a third-quarter adjusted loss of eight cents per share, beating analyst estimates for a loss of 11 cents per share.
Applied Digital shares dipped 10.8% to $4.79 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Emerald Holding, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EEX#NYSE">EEX</a>) fell 12.3% to $3.11 in today's pre-market trading.</li>
<li>Allegro MicroSystems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGM#NASDAQ">ALGM</a>) fell 12.3% to $19.29 in pre-market trading after ON Semiconductor withdrew its acquisition proposal.</li>
<li>Arlo Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARLO#NYSE">ARLO</a>) shares dipped 11.7% to $8.01 in pre-market trading. Arlo Technologies will hold a conference call on Thursday, May 8 to discuss the Company&#8217;s first quarter results.</li>
<li>IRSA Inversiones y Representaciones Sociedad Anónima (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IRS#NYSE">IRS</a>) dipped 11.2% to $12.32 in pre-market trading after gaining around 9% on Monday.</li>
<li>Cullinan Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGEM#NASDAQ">CGEM</a>) shares dipped 10.7% to $6.91 in pre-market trading.</li>
<li>1-800-FLOWERS.COM, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLWS#NASDAQ">FLWS</a>) shares fell 10.7% to $4.75 in pre-market trading.</li>
<li>LATAM Airlines Group S.A. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LTM#NYSE">LTM</a>) dipped 8.2% to $27.01 in pre-market trading.</li>
<li>Cytokinetics, Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTK#NASDAQ">CYTK</a>) fell 7.1% to $37.00 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44787747/wall-streets-most-accurate-analysts-spotlight-on-3-consumer-stocks-delivering-high-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Consumer Stocks Delivering High-Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

Markets

Movers

Trading Ideas

ALGM

APLD

ARLO

CGEM

CYTK

FLWS

Applied Digital Posts Weak Revenue, Joins Allegro MicroSystems And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Barclays analyst Dan Levy downgraded the rating for General Motors Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) from Overweight to Equal-Weight and lowered the price target from $70 to $40. General Motors shares closed at $45.14 on Monday. <a href="https://www.benzinga.com/quote/GM/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Baird analyst Michael Ha downgraded HCA Healthcare, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HCA#NYSE">HCA</a>) from Outperform to Neutral and cut the price target from $396 to $336. HCA Healthcare shares closed at $340.62 on Monday. <a href="https://www.benzinga.com/quote/HCA/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Amy Li downgraded the rating for Ironwood Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRWD#NASDAQ">IRWD</a>) from Buy to Hold and cut the price target from $8 to $0.7. Ironwood Pharmaceuticals shares closed at $0.6479 on Monday. <a href="https://www.benzinga.com/quote/IRWD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jones Trading analyst Catherine Novack downgraded the rating for Rallybio Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RLYB#NASDAQ">RLYB</a>) from Buy to Hold. Rallybio shares closed at $0.2702 on Monday. <a href="https://www.benzinga.com/quote/RLYB/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Dan Levy downgraded Mobileye Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>) from Overweight to Equal-Weight and cut the price target from $22 to $14. Mobileye Global shares closed at $12.94 on Monday.  <a href="https://www.benzinga.com/quote/MBLY/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying GM stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="587" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/15082139/image-112-1024x587.png" alt="" class="wp-image-872090" style="width:609px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/15082139/image-112-1024x587.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/15082139/image-112-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/15082139/image-112-768x440.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/15082139/image-112.png 1085w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44806916/citigroup-bank-of-america-and-3-stocks-to-watch-heading-into-tuesday">Citigroup, Bank Of America And 3 Stocks To Watch Heading Into Tuesday</a> </li>
</ul>
Photo via Shutterstock

MBLY

RLYB

This General Motors Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Biotech

General

HOTH

Hoth Therapeutics Announces Initial Data In CLEER-001 Phase 2a Clinical Trial Of HT-001; Says Patients Experienced A 50% Reduction In Pruritus Severity, With Mean Scores Dropping From 1.6 On Day 1 To 0.8 By Day 21

STLA

Stellantis Chairman Says 'We are encouraged by what
President Trump indicated yesterday on tariffs for the car industry.'

Atlanta, GA, April 15, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. ("Regional") (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/RHEP#OTCQB">RHEP</a>) (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/RHEPA#OTCQB">RHEPA</a>) and SunLink Health Systems, Inc. ("SunLink") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSY#NYSE">SSY</a>) jointly announced today that they have entered into an amended and restated agreement and plan of merger (the "merger agreement"), pursuant to which SunLink will merge with and into Regional (the "merger") in exchange for the issuance of an aggregate of approximately 1,595,401 shares of Regional common stock and 1,408,121 shares of Regional's newly-authorized Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Regional Series D Preferred Stock") with an initial liquidation preference of $12.50 per share. The merger agreement has been approved by each company's board of directors and completion of the transaction remains subject to the receipt of the approvals of the shareholders of both Regional and SunLink, regulatory approvals and satisfaction of customary closing conditions.

RHEP

RHEPA

Sunlink To Merge With Regional Health Properties In Exchange For Regional Series D Preferred Stock With Initial Liquidation Preference Of $12.50/Shr

Seventh generation of industry-leading personal exoskeleton is now available nationwide for individuals with spinal cord injury
New and improved features streamline user experience for greater control, engagement, and confidence during walking in everyday environments
Lifeward Ltd., (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LFWD#NASDAQ">LFWD</a>) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced the U.S. national launch of the ReWalk 7 Personal Exoskeleton, the next generation of its groundbreaking personal exoskeleton technology. The Company will now begin sales of ReWalk 7, which includes innovative new and enhanced features such as cloud connectivity and customizable walking speeds, to provide a more functional and personalized walking experience for individuals with spinal cord injury ("SCI").

LFWD

Lifeward Announces The U.S. National Launch Of The Rewalk 7 Personal Exoskeleton

<a href="https://pr.report/9euq">Twin Vee PowerCats Co.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEEE#NASDAQ">VEEE</a>), ("Twin Vee" or the "Company"), a manufacturer, distributor, and marketer of power sport boats, today announced an update regarding the ongoing development and plans for the full-scale launch of BoatsForSale.com, the Company's strategic digital marketplace designed to transform how new and used boats are marketed and sold across the United States.
BoatsForSale.com is currently undergoing its final migration to Twin Vee's robust, scalable architecture powered by Microsoft Azure and AI Foundry tools, with the full transition expected to be complete no later than May 1, 2025. Tom Huffman, the Company's Chief Information Officer and head of Twin Vee's Digital Division, is overseeing the site's migration and development. "During this first phase, our focus is to connect buyers and sellers by improving listing and search processes, while maximizing SEO and marketing strategies to generate high-quality leads," explained Huffman.
This milestone will mark the official beginning of an aggressive push to onboard dealers nationwide and provide the marine industry with a fresh, fair, and dealer-friendly alternative to legacy classified platforms.
"We've already begun onboarding new dealers and the feedback has been overwhelmingly positive," said Joseph Visconti, CEO and President of Twin Vee PowerCats Co. "Dealers are increasingly frustrated by the rising cost structures imposed by existing platforms like Boat Trader. Articles are being published highlighting dealer backlash and dissatisfaction with these escalating fees. We believe BoatsForSale.com is arriving at the perfect time to offer a smarter, more cost-effective solution."

VEEE

Twin Vee Powercats Issues Update Regarding The Ongoing Development And Plans For The Full-Scale Launch Of Boatsforsale.com, Full Migration Expected By To Be Complete No Later Than May 1, 2025

Stellantis Chairman Says 'In the United States, the car industry is severely affected by tariffs. On top of the 25% tariff imposed on vehicles, we are impacted by layer upon layer of additional compounding tariffs including those on aluminum, steel, and parts.'

Baird analyst Richard Eastman maintains MSA Safety (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSA#NYSE">MSA</a>) with a Neutral and lowers the price target from $175 to $161.

Baird Maintains Neutral on MSA Safety, Lowers Price Target to $161

Although no assurance can be given, the Company is aiming to execute the spin-out of QLE as a separate public company during the 2H25, subject to market conditions and obtaining applicable approvals and consents and complying with applicable rules and regulations and public market trading and listing requirements. While the Company currently expects that a spin-out of QLE as a separate public company is the most likely separation transaction, the board of directors of ASP Isotopes remains committed to maximizing shareholder value creation, and will continue to evaluate other options for separation to maximize shareholder value.

ASPI

Asp Isotopes Aims To Execute Spin-Out Of Quantum Leap Energy As Separate Public Company During 2H 2025

Baird analyst David George maintains M&amp;T Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTB#NYSE">MTB</a>) with a Outperform and lowers the price target from $220 to $200.

Baird Maintains Outperform on M&T Bank, Lowers Price Target to $200

zSpace, Inc., a leading provider of augmented and virtual reality (AR/VR) solutions for education, proudly announces the acquisition of Second Avenue Learning, a Rochester, NY-based innovator in educational technology and interactive learning experiences. This strategic acquisition unites two trailblazers in the EdTech space, poised to transform how students engage with science, math, career and technical education (CTE), and beyond.
zSpace has been at the forefront of immersive learning since its founding in 2007, delivering evidence-based AR/VR platforms that enhance student achievement without the need for head-mounted displays. With its cutting-edge hardware and software, zSpace empowers educators and learners to interact with 3D simulations in subjects ranging from human anatomy to automotive mechanics. Second Avenue Learning, founded by Tory Van Voorhis, complements this mission with its expertise in designing custom educational software, games, and blended learning solutions that prioritize student outcomes and engagement.
The acquisition brings together zSpace's innovative AR/VR technology with Second Avenue Learning's proven ability to craft tailored, technology-driven educational content. We believe this synergy will accelerate the development of comprehensive, hands-on learning tools that meet the evolving needs of K-12, higher education, and workforce development programs globally.
The acquisition of Second Avenue Learning by zSpace could deliver several key benefits. By integrating Second Avenue Learning's expertise in crafting interactive, standards-aligned learning modules, zSpace will significantly enhance its content offerings, equipping educators with a richer set of tools to engage and inspire students. Furthermore, the union accelerates innovation by blending zSpace's proprietary hardware and software strengths with Second Avenue Learning's agile development approach, paving the way for rapid advancements in AR/VR and blended learning applications. Together, the two companies will provide holistic, end-to-end experiential learning solutions that seamlessly fuse immersive technology with curriculum, boosting student engagement and academic success.

ZSPC

zSpace Acquires Second Avenue Learning To Revolutionize Experiential Education; No Financial Terms Disclosed

WATERTOWN, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=JJ37NlN5nCMaYVNcBXW10vsL05t0nPHLxG1SylV5O9Vo4FndimXFJDgZ-7yfW-FRKQp1FMvRHkRCw_BtznlGBR5ztPG6SZGjfVJ78OHw_WA=">Tectonic Therapeutic, Inc</a>.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TECX#NASDAQ">TECX</a>) ("Tectonic"), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors ("GPCRs"), today announced that it will make a late-breaking oral presentation at the European Society of Cardiology (ESC) Heart Failure 2025 Congress. The presentation will highlight Phase 1b data for TX45, Tectonic's lead asset and a long-acting relaxin therapy as a potential best-in-class therapy for patients with Group 2 PH-HFpEF. The presentation at ESC Heart Failure 2025 will include the full Phase 1b PH-HFpEF cohort results for TX45, expanding on the interim data previously announced by Tectonic on&nbsp;January 30, 2025.
ESC Heart Failure 2025 Presentation Details&nbsp;(being held in&nbsp;Belgrade, Serbia, May 17-20, 2025):
<ul>
<li>Title: Hemodynamic effects of TX45 , a long-acting Fc-relaxin fusion, in Group 2 pulmonary hypertension patients.</li>
<li>Presenter:&nbsp;Anthony Muslin, MD, Chief Development Officer</li>
<li>Session: Late-breaking science in heart failure, cardiomyopathies, pulmonary hypertension, and valvular heart disease</li>
<li>Session Date:&nbsp;Saturday, May 17, 2025</li>
<li>Session Time:&nbsp;4:40 p.m. Central European Time&nbsp;/&nbsp;10:40 a.m. Eastern Time</li>
</ul>

TECX

Tectonic Therapeutic To Make Late-breaking Oral Presentation At ESC Heart Failure 2025 Congress Highlighting Phase 1B Data For TX45

Baird analyst Michael Ha maintains Privia Health Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRVA#NASDAQ">PRVA</a>) with a Outperform and raises the price target from $24 to $26.

PRVA

Baird Maintains Outperform on Privia Health Gr, Raises Price Target to $26

New capabilities can enable the US Army to cost-effectively modernize its operations
WASHINGTON, April 15, 2025 /PRNewswire/ -- Oracle Federal Forum --&nbsp;Oracle today announced a firm-fixed price task order through the U.S. Department of Defense (DoD) <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4405517-1&amp;h=2141457969&amp;u=https%3A%2F%2Fwww.defense.gov%2FNews%2FContracts%2FContract%2FArticle%2F3239197%2F&amp;a=Joint+Warfighting+Cloud+Capability">Joint Warfighting Cloud Capability</a>&nbsp;(JWCC) contract to provide the U.S. Army's Enterprise Cloud Management Agency (ECMA) with cloud compute and storage services. These services, delivered via <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4405517-1&amp;h=2679965717&amp;u=https%3A%2F%2Fwww.oracle.com%2Fgovernment%2Fgovcloud%2Fdefense%2F&amp;a=Oracle+U.S.+Defense+Cloud">Oracle U.S. Defense Cloud</a>, will cover Defense Information Systems Agency (DISA)&nbsp;Impact Levels (IL) 2, 4, 5, and 6. ECMA is a field operating agency under the U.S. Army's Office of the CIO.
Building on the DoD's <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4405517-1&amp;h=4206471408&amp;u=https%3A%2F%2Fwww.oracle.com%2Fnews%2Fannouncement%2Fus-army-to-modernize-its-personnel-and-pay-system-on-oracle-cloud-infrastructure-2024-10-16%2F&amp;a=largest+competitive+JWCC+award">largest competitive JWCC award</a>&nbsp;in 2024, this new task order will help advance the ECMA's mission to deliver and manage a secure, multicloud ecosystem in support of the <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4405517-1&amp;h=1900538457&amp;u=https%3A%2F%2Fapi.army.mil%2Fe2%2Fc%2Fdownloads%2F2021%2F10%2F20%2F3b64248b%2Farmy-digital-transformation-strategy.pdf&amp;a=Army+Digital+Transformation+Strategy">Army Digital Transformation Strategy</a>&nbsp;(ADTS). In addition, by expanding ECMA's catalog of cloud capabilities, the new task order will enable Army customers to further innovate across all operational domains.

ORCL

U.S. Army Enterprise Cloud Management Agency Expands Its Oracle Defense Cloud Services

MARLBOROUGH, Mass., April 15, 2025 /PRNewswire/ --&nbsp;ConnectM Technology Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNTM#NASDAQ">CNTM</a>) ("ConnectM" or the "Company"), a high-growth technology company on the leading edge of the energy economy, today announced that Win-Light Global Co. Ltd. ("Win-Light"), one of ConnectM's largest stockholders and a member of the investor group that initiated a buy-out offer on March 31, 2025 (the "Buy-Out Group"), has acquired an additional 1,479,890 shares of the Company's common stock.
Following this latest acquisition, the Buy-Out Group comprising Win-Light, SriSid LLC, and Arumilli LLC now collectively holds 9,490,496 shares of ConnectM. This represents an 18.5% increase from the 8,010,496 shares disclosed in the Buy-Out Group's initial offer letter dated March 31, 2025.
The increased ownership further supports the Buy-Out Group's previously announced proposal to acquire all remaining outstanding shares of ConnectM at a cash price of $1.60 per share. As disclosed in prior communications, based on the Company's current shares outstanding of 38.76 million, the proposed transaction implies a total equity value of approximately $62 million.
The ConnectM Board of Directors continues to evaluate the buyout proposal with the assistance of its financial advisor, ThinkEquity, and remains focused on ensuring the best possible outcome for all stockholders.

CNTM

Win-Light Global Announces Acquisiton Of Additional 1,479,890 ConnectM Shares, Stake Now 24.5% Of Shares Outstanding. Proposed Transaction Implies A Total Equity Value Of ~62M

UBS analyst Taylor McGinnis upgrades HubSpot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUBS#NYSE">HUBS</a>) from Neutral to Buy and lowers the price target from $775 to $675.

Upgrades

HUBS

UBS Upgrades HubSpot to Buy, Lowers Price Target to $675

Financing

Legal

Press Releases

MSP Recovery Announces Strategic Term Sheet Providing Prospective Liquidity and Restructuring of Existing Agreements to Remove Corporate Guaranteed Debt by over $1.2 Billion as Well as New Agreements Aimed at Driving Future Growth

MSPR

American Shared Hospital Services Common Stock

American Shared Hospital

Basel Medical Group Ltd - ordinary shares

Basel Medical Group

Cryo-Cell International, Inc. Common Stock

Cryo-Cell International

Enzo Biochem, Inc. Common Stock ($0.01 Par Value)

Enzo Biochem

Kindly MD

Mobile-health Network Solutions - Class A Ordinary Shares

Mobile-health Network

ModivCare

NewGenIvf Group Limited - Class A Ordinary Shares

NewGenIvf Group

Ontrak

P3 Health Partners Inc. - Class A Common Stock

P3 Health Partners

Prenetics Global Limited - Class A Ordinary Share

Comments

MSP Recovery

MSP Recovery (MSPR) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO